Cardio Drug Discovery
Human induced pluripotent stem cell cardiomyocytes (hiPSC-CM) offer an exciting new model system to test both the efficacy and toxicity of new therapeutic approaches, including inotropic compounds that serve to modulate the force of cardiomyocyte contractility.
Real-Time Cell Analysis for Cardiovascular Research
Real-time, functional cell analysis of cardiomyocytes provides novel and sensitive measurements for cardiac disease research to reveal critical pathways and identify drug targets.
With Agilent cell analysis technologies, expand your drug development pipeline by examining drug compounds affecting contractile processes, cardiotoxicity, cardiovascular disease, and cardiac safety. Perform disease-specific modeling with human induced pluripotent stem cell cardiomyocytes (hiPSC-CM) to understand the underlying causes of these cardiomyopathies.